Dr. Walter BialkowskiÃÛÌÒÓ°ÏñCudahy Hall, 240H
MilwaukeeWI53201United States of America(414) 288-2005walter.bialkowski@marquette.eduDr. Bialkowski is trained as a clinical epidemiologist and translational data scientist. He first worked professionally as a Project and Program Manager in resuscitation research involving out-of-hospital cardiac arrest, traumatic brain injury, and hypovolemic shock clinical trials. He later moved into a Program Director role in the field of transfusion medicine and led several projects including observational and interventional clinical studies. He was part of a large team that linked non-interoperable medical records throughout the United States in efforts to understand transfusion safety and efficacy.
As an educator, Dr. Bialkowski prioritizes applied learning of data science skills. Students in his classes, and those involved in his research program, apply data science skills through individual assignment and project work. His courses engage with students across disciplines, including sports and exercise, criminal justice, accounting, healthcare, and many professional industries. Current research efforts aim to apply data science techniques in the field of food insecurity and hunger relief in Wisconsin. Through community partnerships, his team is working to meaningfully improve charitable food provision nationwide.
Ph.D. Clinical and Translational Health, ÃÛÌÒÓ°Ïñ, Milwaukee, WI
M.S. Comparative Pathobiology, Purdue University, West Lafayette, IN
B.S. Biology, University of Wisconsin, Oshkosh, WI
Ko J-L, Joslyn J, Lu G, Palmer J, Charles M, Stapleton M, Sanganalu Mattha A, Parsons B, Tatum R, Redmann C, Yu H, Moy A, Bialkowski W. Empowering those who seek to end hunger through collaboration and data science innovation. Metropolitan Universities 2022; 33 (1): 92-101.
Bialkowski W, Tan S, Mast AE, Kiss JE, Kor DJ, Gottschall J, Wu Y, Roubinian N, Triulzi D, Kleinman S, Choi Y, Brambilla D, Zimrin A. Equivalent inpatient mortality among direct-acting oral anticoagulant comparared to warfarin users presenting with major hemorrhage. Thrombosis Research 2019; 185: 109-118.
Walderhaug M, Whitaker B, Hinkins S, Steele W, Custer B, Kessler D, LeParc G, Gottschall J, Bialkowski W, Stramer S, Dodd R, McEwen S, Crowder L, Vahidnia F, Shaz B, Kamel H, Rebosa M, Stern M, Anderson S. Use of a rapid electronic survey methodology to estimate blood donors’ potential exposure to emerging infectious diseases. Accepted for Publication, Transfusion.
Spencer BR, Bialkowski W, Creel DV, Cable RG, Kiss JE, Stone M, McClure C, Kleinman S, Glynn SA, Mast AE. Elevated Risk for Iron Depletion in High-School Age Blood Donors. Transfusion 2019; 59(5): 1706-1716.
Bialkowski W, Blank RD, Zheng C, Gottschall J, Papanek P. Impact of frequent apheresis blood donation on bone density: a prospective, longitudinal, randomized, controlled trial. Bone Reports 2018 Dec; 10: 100188.
Bialkowski W, Kiss JE, Wright DJ, Cable R, Birch R, D’Andrea P, Bryant BJ, Spencer BR, Mast AE. Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy. Am J Hematology 2017; 92(9):851-857.
Grau KG, Vasan SK, Rostgaard K, Bialkowski W, Norda R, Hjalgrim H, Edgren G. No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden. Transfusion 2016; 57(2): 390-396.
